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ABSTRACT 
Cell encapsulation is a micro technology widely applied in cell and tissue engineering, 
tissue transplantation and regenerative medicine. Various techniques had been 
developed for microencapsulation of cells but these techniques presented threat to the 
cells due to the harsh or chemical treatment applied. In this research, a simple and 
economic electronic aerosol atomisation system was proposed for producing calcium 
alginate microcapsules. The system was developed with the incorporation of a 
conventional syringe pump, a customised air pump and motor controller circuits. The 
microcapsules and 3D microtissues were biophysically characterised. For the output of 
the system, the microcapsules size slightly increased with the extrusion rates and 
decreased significantly with the airflow rates. At an extrusion rate of 20 µl/min and 
airflow rate of 0.3 l/min, microcapsules with a diameter ranging from 220 - 270 µm 
were generated. The polymerisation time for the microcapsules was approximately 10 
minutes after the immersion in calcium chloride solutions. The microcapsules showed 
high porous surface structure in field emission-scanning electron microscopy (FE-SEM) 
imaging. Keratinocytes (HaCaT) and Oral Squamous Cell Carcinoma (ORL-48) cells at 
cell densities of 3 × 107 and 9 × 107 cells/ml, respectively were applied for encapsulation 
and successfully grew into microtissues after 16 days of culture. The fourier transform 
infrared (FTIR) spectroscopy of the 3D cells showed stretching in phosphate bond of 
Deoxyribonucleic acid (DNA) and Ribonucleic acid (RNA) backbone, lipid and protein. 
The cells of HaCaT and ORL-48 microtissues were viable and they were characterised 
by different nucleus size. Replating experiment demonstrated that the cells in the 
microtissues could spread and proliferate in the culture dish. The electronic aerosol 
atomisation system developed in this work has successfully produced microcapsules 
with controllable size and applicable for growing microtissues. The microtissues 
produced are potentially a useful cell model for the study of cytochemicals. 
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ABSTRAK 
Pengkapsulan sel adalah teknologi mikro digunakan secara meluas dalam bidang 
penyelidikan sel dan tisu, pemindahan tisu dan perubatan regeneratif. Pelbagai teknik 
telah dibangun untuk menghasilkan kapsul mikro untuk membalut sel tetapi memberi 
ancaman kepada sel disebabkan layanan kasar atau kimia semasa proses pengkapsulan. 
Dalam kajian ini, sistem pengabusan aerosol elektronik yang mudah dan ekonomi telah 
dicadang untuk menghasilkan kapsul mikro kalsium alginat. Sistem ini dibangunkan 
dengan penggabungan pam picagari konvensional, pam udara dan litar pengawal motor. 
Kapsul mikro dan tisu mikro telah dicirikan. Bagi output sistem, saiz kapsul mikro 
menunjukkan sedikit peningkatan dengan kadar penyemperitan dan menurun nyata 
sekali dengan kadar aliran udara. Pada 20 µl/min kadar penyemperitan dan 0.3 l/min 
kadar aliran udara, kapsul mikro dengan diameter 220 - 270 µm telah dihasilkan. Masa 
jangkaan polimerisasi kapsul mikro adalah 10 minit selepas rendam dalam larutan 
kalsium klorida. Kapsul mikro menunjukkan struktur permukaan yang berliang tinggi 
dalam pengimejan mikroskopi elektron imbasan-emisi medan (FE-SEM). Sel 
keratinocytes (HaCaT) dan Oral Squamous Cell Carcinoma (ORL-48) pada kepadatan 3 
× 107 dan 9 × 107 sel/ml telah digunakan untuk pengkapsulan dan berjaya tumbuh 
menjadi tisu mikro selepas 16 hari kultur. Inframerah transformasi Fourier (FTIR) bagi 
sel 3D menunjukkan peregangan ikatan fosfat dalam tulang belakang asid 
deoksibonukleik (DNA) dan asid ribonukleik (RNA), lipid dan protein. Sel tisu mikro 
HaCaT dan ORL-48 hidup tetapi menunjukkan perbezaan dalam saiz nukleus. 
Eksperimen pemplatan semula menunjukkan bahawa sel-sel dalam tisu mikro boleh 
mengasingkan diri dan proliferat dalam bekas kultur. Sistem pengabusan aerosol 
elektronik dihasil dalam kerja ini berjaya menghasilkan saiz kapsul mikro yang boleh 
dikawal dan dapat digunakan untuk menumbuh tisu mikro. Tisu mikro yang dihasilkan 
adalah berpotensi untuk dijadikan model sel yang berguna untuk kajian sitokimia. 
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CHAPTER 1 
INTRODUCTION 
1.1 Research background 
Monolayer cultures in plastic vessels are routinely used in biological studies. However, 
the use of two-dimensional (2D) cell models for cell biological studies has its limitations 
[1, 2]. In 2D culture, the proliferation, differentiation, gene and protein expression, 
functionality and morphology of cells is considerably different from their physiological 
origin in vivo [3]. By contrast, the three-dimensional (3D) cell culture creates an 
artificial environment where cells are permitted to grow or interact with its surroundings. 
3D cell culture is believed to have a better approximation to the tissue model for cell and 
tissue research because it restores specific biochemical and morphological features 
similar to the corresponding tissue in vivo [4]. In 3D cell culture, the connections 
between cells are more native-like and the behaviour of cells is more reflective of in vivo 
cellular responses [3, 5]. 
   Regenerative medicine or biotechnology for creating living functional tissues in 
vitro is urgently needed for repair or replacement of damaged organs [6], application in 
cell culture and tissue engineering [7], pharmacological testing and bioengineering fields 
[8]. Microencapsulation is an intensive research area to create cell and tissue model for 
rehabilitation of functional tissues [9] and therapeutics purpose [10, 11]. It is a technique 
which encloses cells within a membrane or shell. It has been widely studied since 1960s 
[12]. A microcapsule is a hollow chamber with diameters in the range of a few 
micrometers to several thousands of micrometers [13, 14]. The semipermeable 
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membrane of the microcapsule can facilitate the transportation of proteins, 
deoxyribonucleic acid (DNA), and drug and allows the diffusion of oxygen, nutrients, 
therapeutic products and wastes, while blocking the entry of antibodies and 
immunocytes [15]. In tissue transplantation, microcapsules segregate cells from the 
surrounding tissue to protect the implanted cells from the recipient‟s immune system 
[16]. Therefore, cell encapsulation in biocompatible and semipermeable biopolymeric 
membranes is an effective method to overcome rejection of the implanted organ [17]. 
There are various types of biopolymer such as agarose, collagen, alginate, 
chitosan and gelatin that are widely applied for encapsulation of cells [14, 18]. These 
materials are different in polymerisation process and hence this consideration greatly 
influences the design of the microencapsulation system. Among them, alginate is the 
most commonly used biopolymer for encapsulation of living cells because of many 
advantages it offers [19, 20]. Alginate is a naturally derived polymer, biocompatible in 
vitro and in vivo, with excellent biodegradability and provide rapid gelation process in 
the presence of divalent cations at room temperature [21]. Indeed, alginate has been 
employed for encapsulating cells and tissues to be transplanted into human body, as it is 
biocompatible to both the host and the enclosed cells [22]. Furthermore, alginate has 
been studied extensively and it is currently recognised as a clinically ready application 
material by the United States Food and Drug Administration (US FDA) [15, 23]. 
A few methods had been developed for the microencapsulation of cells such as 
simple dripping [24, 25], micromolding [26, 27], extrusion [28], microfluidic device [29, 
30], electrostatic droplet generation [31-33], coaxial air-flow [34-36], vibration [37] and 
jet cutting techniques [38-40]. For simple dripping technique, the diameter of the 
capsules produced is usually ranging between 600 and 1000 µm [41]. This technique is 
used to produce microcapsules that does not involve with chemical or mechanical 
treatment. Other techniques such as microfluidic, micromolding and electrostatic 
dropping could produce smaller size of microcapsules ranging from 200 to 600 µm [34] 
but these techniques are considered harsh because involvement of the organic solvent, 
oil phase, high voltage and ultra-violet treatment to produce the microcapsules. The 
requirement for post-processing treatment due to the harsh generation techniques may be 
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threatening the survival rate of the living organism encapsulated in the microcapsules [8, 
28, 42]. 
Amongst previous methods discussed [26-28, 30-33, 37-39, 43], aerosol 
atomisation technique is a simple and efficient method to generate microcapsules with 
well-controlled size and shape without the use of harsh chemicals [19, 36, 44]. In this 
study, an electronic aerosol atomisation system had been developed for the generation of 
3D human keratinocytes (HaCaT) and oral squamous cell carcinoma (OSCC) cells 
(ORL-48) in microencapsulations of calcium alginate that leads to the growth of 3D 
microtissues in vitro. 
1.2  Problem statement  
Alginate based capsules can be generated by simply extruding droplets of sodium 
alginate solution from a syringe needle and the droplets are immediately allowed to 
polymerise in the calcium chloride bath. However, the simple dripping technique usually 
produced large diameter capsules of alginate in millimeter, that were recognised as 
unsuitable for medical and biotechnological applications [37, 45]. The size of the droplet 
is mainly dependent on the orifice diameter [46] and dripping can only be achieved 
when the extruded droplet‟s of alginate continue to grow until its mass overcomes the 
surface tension at the tip of the needle [47]. Because of this limitation, other approaches 
have been developed to create microcapsules with smaller diameter [43]. Smaller 
alginate capsules in micron size are desirable because this range of microcapsules can 
equilibrate rapidly across the ultrathin membrane with larger surface to volume 
relationship, and hence provide better transport of gases and nutrients for the 
encapsulated cells [48]. Generation of alginate droplets by the electrostatic and JetCutter 
technique were shown to decrease the size of the droplets or capsules compared to 
normal dripping [24]. However, these techniques required sophisticated high voltages or 
strong electric fields, complex and bulky design of devices, respectively, that might be 
of high demand of energy and time during the fabrication of microencapsulation system 
[39, 49-51]. Microcapsules formed based on microfluidic emulsion technique are 
covered with oil and hence post-processing treatment is required to remove the oil film 
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for application in cell microencapsulation [52]. This is because the oil layer could block 
the exchange of gas and nutrient to the cells in the microcapsules. Involvement of harsh 
treatment to remove the oil film causing the cells in the microcapsules exposed more to 
the divalent ions or solvents which may present threats to the survival rate of the cells [8, 
28]. Hence, the simpler the production process(without harsh and post-processing 
treatment), the less threat to the cells whilst ensuring cells to proliferate in the 
encapsulations. 
In this thesis, an electronic aerosol atomisation system is proposed to generate 
the desired size of calcium alginate microcapsules for the microencapsulation of cells. 
Although the aerosol atomisation method has been developed previously [53, 54], but 
the microcapsules size was ranging from 10 to 40 µm which is too small and not suitable 
for cells encapsulation. Current applications (air jets, fuel injection and spray coating) 
based on aerosol atomisation technique required high air flow rate (50 - 600 l/min) and 
large volume (millilitre) of solution to create small beads size (approximately 1 - 3.5 
µm) [55]. Thus, an adjustable electronic aerosol atomisation system employed for this 
research was designed to produce different airflow rates (0.2 - 0.5 l/min), in which it can 
be used to disperse small volume of cells-alginate suspension (microlitre) and to 
generate larger size of microcapsules with controllable size (range in 80 - 360 µm) 
which is suitable for cells encapsulation. Instead of using compressed air from a gas 
cylinder [19, 36] which is costly, the electronic aerosol atomisation system presented a 
different approach in the generation of airflow by using a direct current (dc) air pump. 
Moreover, this research applied OSCC and HaCaT cell lines for the microencapsulation 
that had not been reported previously. Oral cancer is the most common disease and it is a 
silent killer in the developing world, particularly in Southeast Asia country [56, 57]. 
Although the etiological factors of oral cancer are well established, the mechanism 
developed has rarely been studied and it is not well understood [56, 57]. In vitro 
microtissues models of OSCC could support the cancer research. Therefore, 
development techniques for generation of OSCC and HaCaT microtissues are essential. 
The OSSC (ORL-48) and HaCaT cells encapsulated are expected to grow into 
microtissues models that have applications for pharmacology study and preliminary 
prediction performance of their efficacy in therapeutic strategies. 
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1.3 Aim 
The aim of the research is to develop an electronic aerosol atomisation system to 
generate calcium alginate microcapsules that are size controllable and able to 
encapsulate cells that leads to the growth of 3D microtissues. 
1.4 Objectives  
The following research objectives were established to achieve the aim. The objectives 
for this research are: 
 
a) To develop an electronic aerosol atomisation system for generating calcium 
alginate based microcapsules of cells. 
b) To encapsulate human Keratinocytes (HaCaT) and OSCC cell lines (ORL-48) 
using microcapsules of calcium alginate to form 3D cells. 
c) To characterise the biophysical properties of calcium alginate microcapsules 
and the 3D microtissues produced. 
1.5 Scopes  
The four scopes of the research work are as follows: 
 
a) Development and characterisation of an electronic aerosol atomisation 
system to generate microcapsules.  
b) Synthesis of calcium alginate microcapsules with a diameter ranging from 
200 to 300 µm, as the thickness of human epidermis by using an aerosol 
atomisation system. 
c) Determine the extrusion rates and airflow rates of the aerosol atomisation 
system to generate appropriate size of microcapsules for cell encapsulation. 
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d) Encapsulation of HaCaT and OSCC (ORL-48) cells using calcium alginate to 
form 3D cells, monitor their growth in the encapsulation and investigate their 
biophysical properties. 
1.6 Thesis contribution 
The main contributions of this thesis are: 
a) Electronic aerosol atomisation system with controllable airflow rate 
 
The aerosol atomisation system has revived previous cell encapsulation techniques with 
no post-treatment process, no complex fabrication design of nozzle or high voltage 
requirement that would affect the cell survival rate in the alginate microcapsules [8, 28, 
29, 42, 58].  
 
b) Round shape and suitable size of 3D cells generated for the application 
 
The findings obtained from the aerosol atomisation system have contributed to the 
understanding of how alginate is involved in driving the growth of both HaCaT and 
ORL-48 microtissues whereby the microcapsules and 3D cells generated were round 
shape and in consistent size [8, 30]. 
 
c) Encapsulate new cell lines of HaCaT and ORL-48  
 
This is the first demonstration of microencapsulation of HaCaT and ORL-48 using 
calcium alginate microcapsules to be applied as a cell model for cancer research.  
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1.7 Thesis outline 
Chapter 1 introduces the overview of this project with technology and technique of 
microencapsulation. The problems of the current 3D cell encapsulation technique were 
discussed, followed by the problem statement, aims, objectives, scopes, thesis 
contribution and thesis outline. 
 Chapter 2 consists of the review of the essential background study information in 
understanding the current body knowledge of microencapsulation and the latest 
development or technique developed in the field associated with the research topic. 
 Chapter 3 presents the methodology used to develop the electronic aerosol 
atomisation system and technique to produce 3D cells based on the calcium alginate 
microencapsulation. Calcium alginate microencapsulation to generate 3D cell technique, 
the development of an electronic aerosol atomisation system, the programming of 
microcontroller of the air pump, the circuit design and simulation of the aerosol 
atomisation system, the procedure in preparing the cells and calcium alginate for 
microencapsulation and the biophysical properties characterisation of the microcapsules 
and microtissues were discussed. 
 Chapter 4 unveils the performance of the aerosol atomisation system based on 
the pulse width modulation (PWM), potentiometer voltage and the effects of airflow rate 
and extrusion rates to the size of microcapsules. The biophysical properties of 
microcapsules generated were assessed using the optical microscopy, fourier transform 
infrared spectroscopy (FTIR) and field emission-scanning electron microscopy (FE-
SEM). The growth of 3D HaCaT and ORL-48 cells into microtissues were monitored 
using inverted phase contrast and fluorescence microscopy. Nonetheless, the results of 
the biophysical properties of the microtissues formed were reported and discussed. 
 Chapter 5 summarises the problem statement that have been solved, the 
objectives that have been achieved and the future works to enhance this research. 
 
 
 
  
CHAPTER 2 
LITERATURE REVIEW 
2.1 Introduction 
This chapter discussed and explained the background knowledge and information of 
cells and tissues, types of epithelial cells applied for microencapsulation, rationale of 
growing 3D cells, microencapsulations, applications of microcapsules, 
microencapsulation technics, biopolymers used for fabrication of microcapsules for cell 
microencapsulation and the review on microscopy and spectroscopy techniques applied 
in this research. 
2.2 Cells and tissue 
The basic building blocks of all living things is cell [59]. Cells provide structure for 
human body, take in nutrients that are consumed, convert it into energy, and use them to 
carry out specialised functions. Organelles are specialised structures that perform 
important cellular functions within the cell. Human cells contain nine major organelles 
such as the cytoplasm, cytoskeleton, endoplasmic reticulum (ER), golgi apparatus, 
lysosomes, mitochondria, nucleus, plasma membrane and ribosomes as shown in Figure 
2.1.  
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Figure 2.1: The anatomy of human cell [60] 
Tissue is structural organisation of cells with similar or identical specialised 
characteristics, contributing to the performance of a specific function. Tissues are parts 
of organs that provide numerous functions of organs necessary to maintain biological 
life. In humans, there are four basic types of tissue, which are epithelial, connective, 
muscular, and nervous tissues (Figure 2.2). Epithelial tissue covers the body surface and 
forms the lining for most internal cavities.  The major function of epithelial tissue 
includes protection, secretion, absorption, and filtration. The skin is an organ made up of 
epithelial tissue which protects the body from harmful microbes [61]. Cells of the 
epithelial tissue have different shapes. Connective tissue is tissue that supports and binds 
other tissues. It consists of connective tissue cells embedded in a large amount of 
extracellular matrix. 
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Figure 2.2: The four basic types of tissue [62] 
2.2.1 Extracellular matrix (ECM) and cell adhesion 
All cells in solid tissue are surrounded by extracellular matrix (ECM). ECM is 
composed of proteins and polysaccharides. In animal cells, the ECM surrounds cells as 
fibrils that contact the cells. Cells are linked directly to each other by cell adhesion 
molecules at the cell surface. ECM provides mechanical support [63], a biochemical 
barrier [64], a medium for extracellular communication [65], cell matrix adhesion [66], 
and  adhesion matrix for cell migration [67-69] during cell development. 
Adhesion of cells to the ECM is key to the regulation of cellular morphology, 
migration, proliferation, survival, and differentiation [70]. These functions are essential 
during development, maintenance of tissue architecture and the induction of tissue 
repair. Integrin are the predominant receptors that mediate cell adhesion to the ECM 
proteins [71, 72].  
Attachment of cells to ECM components induces clustering of integrin on the 
cell surface [73]. The cytoplasmic portions of the clustered integrin then function as a 
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platform for the recruitment of cellular proteins and signaling proteins to the inner 
surface of the plasma membrane, where they form structures called focal adhesions (FA) 
(Figure 2.3 (a)) [74]. The FA provide strong linkages to the actin cytoskeleton mediated 
by integrins to connect cells firmly to the ECM [75].  
Cells adhere to the ECM via integrins that function as a heterodimer that 
composed of subunits alpha (α) and beta (β) transmembrane linked to cell cytoskeleton 
actin microfilaments via talin and vinculin [76]. Talin is a main regulator of the initial 
process of FA assembly [77]. During the initial step of FA formation, the binding of 
talin to integrin stabilises the ligand-induced clustering by mediating crosslinking of 
integrins with vinculin and α-actinin (Figure 2.3(b)) [78].  
(a) 
 
 
 
(b) 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Cell adhesion to the ECM. (a) Suspended cells adhere to the surface of ECM 
via integrins (b) The structures of actin cytoskeleton, focal adhesion complexes, integrin 
receptors, and adhesion proteins to form cross-linked platforms 
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2.3 Epithelial cells and skin 
HaCaT and OSCC (ORL-48) are non-cancer and cancer epithelial cells, respectively. 
The microtissue models for epidermis and oral cancer cell study are scarce. Hence, the 
growth of both cell types into biomimetic microtissues would provide value in tissue 
implant [79], pharmacology [80] or even cancer therapeutic drugs study [11]. 
2.3.1 Human keratinocyte cell lines (HaCaT) 
The epidermis is a squamous epithelium that forms the protective layer of the skin. It 
consists of renewing tissue with the main cell type (keratinocytes), superpositioned and 
organised into four histologically distinct cellular layers: stratum corneum, stratum 
granulosum, stratum spinosum and stratum basale [81]. The HaCaTs have a close 
similarity in functional competence to normal keratinocytes [82]. HaCaT is a 
spontaneously immortalised and transformed aneuploidy immortal keratinocyte cell line 
from adult human skin [83]. The naturally immortalised human HaCaT cell line can be 
grown in culture vessel (Figure 2.4) for long periods of time [84]. This cell line has been 
widely used for studies of skin biology, differentiation and scientific research as a 
paradigm for epidermal cells [84-86]. HaCaT grew in the form of monolayer and 
adherent to the culture dish easily. Under typical culture conditions, HaCaT cells have a 
partially to fully differentiated phenotype due to the high calcium content of both 
standard media and fetal bovine serum. HaCaT cells are used for high differentiate and 
proliferate capacity in vitro [87]. HaCaT cells drastically reduced tissue regeneration 
compared to normal epidermal keratinocytes [88, 89]. The deficiency in HaCaT cells 
were not due to the permanent loss of differential functions and can be solved by the 
addition of growth factors [84].  
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Figure 2.4: Phase contrast micrographs of HaCaT cells cultured for 3 days at 1 : 6 
dilutions (Scale bar: 100 µm) 
2.3.2 Oral squamous cell carcinoma cell line (ORL-48) 
Oral cancer is defined as malignant lesion within oral cavity. Most cancerous oral cells 
originate from the oral squamous epithelium cell which is the primary surface structure 
of the lips and mucous membrane of the oral cavity [90]. OSCC has been histologically 
characterised as irregular nests, columns or malignant epithelial cells [91]. 
Abnormalities of oral cancerous cells are believed to be associated with several 
consecutive genetic mutations [92]. By clonal selection of viable cells which have 
accumulated genetic damages, normal mucosa cells ultimately evolve into malignant 
mucosa cells over an indefinite period [93].  
ORL-48 is one of the OSCC cell lines derived in Cancer Research Malaysia. 
ORL-48 was surgically explanted specimens obtained from untreated primary human 
oral squamous cell carcinomas of the oral cavity [56]. It was derived from a female 
donor patient at the age of 79 years old having cancer tumour in the mouth and gum 
[56]. ORL-48 cell lines grew in the form of monolayers (Figure 2.5) with the population 
doubling times ranging between 26.4 and 40.8 hours and they are immortal [56]. 
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Figure 2.5: Phase contrast micrographs of ORL-48 cells cultured for 3 days at 1 : 6 
dilutions (Scale bar: 100 µm) 
2.4 Rationale of growing 3D cells 
Sub-culturing monolayer of cells in plastic vessels is a routine procedure for cell biology 
study. However, the validity of using such a 2D cell model for cell biology or 
pharmacological study is controversial [1, 2]. Cells grown in monolayer proliferate 
involuntarily due to the contactless spreading of cells and it has been shown to produce 
limited amount of extracellular matrix proteins [94]. The cell behaviour such as 
proliferation, differentiation, gene and protein expression, general cell function and 
morphology is considerably different from their physiological origin in vivo [3]. In 
contrast, 3D cell culture creates an artificial environment in which biological cells are 
allowed to grow and interact with its surrounding environment in three dimensional. 3D 
cell culture is also proven to have better approximation to the tissue model for cell and 
tissue research because it reconstructs specific biochemical and morphological features 
similar to the tissue in vivo [4]. The connections between cells are more native-like and 
the cellular behaviour is more realistic. 
15 
 
   
  
2.5 Methods for culturing microtissues 
3D cell culture methods are commonly accepted as more physiologically relevant 
methods and are believed to improve prediction of drug development process [95, 96]. 
There are several methods for culturing cells into 3D microtissues, which involved 
scaffolds, matrices (scaffold-free), gels or hydrogels and bioreactor as listed in Table 
2.1. Scaffold based method is available in variety of materials with different porosities, 
permeabilities and mechanical characteristics designed to mimic the in vivo ECM of the 
specific tissues [1]. Whereas, microtissue culture using scaffold-free platforms do not 
contain added biomaterials or ECM. Cells grown and organised with their own 
generated ECM [96]. Gels or hydrogels culturing method aim to mimic the ECM and it 
has a soft tissue-like stiffness [97]. Cells can be cultured directly on the hydrogels 
(agarose, collagen and alginate) to form microtissues [98-100]. This method can be 
combined with other methods, such as scaffolds and microchips. The most ideal 3D cell 
culture method for high volume cell production and in vitro tissue engineering 
applications are the bioreactors method [101]. Microtissues cultured by using bioreactor 
method allows circulation of nutrients and removal of wastes within the reactor. 
Table 2.1: A summary of 3D cell culture methods for culturing 3D microtissues 
 
Methods Advantages Disadvantages Applications Reference 
a) Scaffolds 
• Polymeric Hard Scaffolds  
 
• Biologic Scaffolds   
• Micropatterned Surface  
 
 Large variety of 
materials possible 
for desired 
properties 
 Customisable 
 Co-cultures 
possible 
 Medium cost 
• Possible scaffold-
to-scaffold 
variation 
• May not be 
transparent 
• Cell removal may 
be difficult 
• High-throughput 
screening (HTS) 
options limited 
• Basic research 
• Drug discovery 
• Cell expansion 
[102-105] 
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Table 2.1 (continued): A summary of 3D cell culture methods for culturing 3D 
microtissues 
 
Methods Advantages Disadvantages Applications Reference 
b) Matrices  
(Scaffold-free) 
• Hanging Drop Microplates  
 
• Microfluidic  
 
• Microarray  
 
 No added 
materials 
 Consistent 
spheroid 
formation 
(control over 
size) 
 Co-cultures 
possible 
 Transparent 
 HTS capable 
 Compatible with 
liquid handling 
tools 
 Inexpensive 
 No support or 
porosity 
 Limited 
flexibility 
 Size of spheroid 
limiting 
 Basic research 
 Drug discovery 
 Personalised 
medicine 
[96, 106, 
107] 
c) Gels / Hydrogels  
• Micromold 
 
• Microencapsulation  
 
• Large variety of 
natural or 
synthetic 
materials 
• Customisable 
• Co-cultures 
possible 
• Inexpensive 
• Gel-to-gel 
variation and 
structural changes 
over time 
• Undefined 
constituents in 
natural gels 
• May not be 
transparent 
• HTS options 
limited 
• Basic research 
• Drug discovery 
[103, 104, 
108] 
d) Bioreactor  
 
• Several options 
available 
• High volume cell 
production 
• Customisable 
• Cost 
• HTS options 
limited 
• Basic research 
• Tissue 
engineering 
• Cell expansion 
[101] 
2.6 Microencapsulation 
Microencapsulation is a technology of packaging solids, liquids or gases to be 
encapsulated inside a tiny sphere, called microcapsule. A microcapsule is a small sphere 
with hollow chamber, micro-porous and semi-permeable wall around it [109]. 
Microencapsulation of active compounds is defined as a series of techniques whereby a 
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compound is coated or masked, to present it in the form of multiparticulate system. 
Microencapsulation process can be classified in terms of the microparticles or 
microspheres, based on their external morphology and internal structure (homogeneous 
or solid spheres) in micrometer range diameters [13, 34]. The material inside the 
microcapsule is referred to as the core, internal phase, or fill, whereas the wall is 
sometimes called a shell, coating, or membrane. Microcapsules can be classified into 
three basic categories as mono-core (also called single-core or reservoir type), poly-core 
(also called multiple-core) and matrix types (Figure 2.6). Mono-core is microcapsule 
which has a single hollow chamber within the capsule [110]. Poly-core is microcapsule 
which has a number of different size chambers within the shell [110]. Matrix type is of 
microparticle that has the active compounds integrated within the matrix of the shell 
material [110]. However, the morphology of the internal structure of a microparticle 
depends mainly on the shell materials and the microencapsulation methods that are 
employed [110]. 
 
 
  
 (a)        (b)      (c)   (d) 
 (a)       (b)     (c)   (d) 
 
 Figure 2.6: Different morphology of microcapsules. (a) Mono-core, Single-core or 
reservoir type, (b) Poly-core, Multiple-core, (c) and (d) Matrix type [110] 
 The main functions of microencapsulation are to isolate, immobilise, stabilise 
and protect the core from its surroundings. Capsular membrane is to shield the material 
within and control the flow of materials across the membrane (Figure 2.7). It allows 
manipulating the diffusion rate of molecules leaving the microcapsule under specific 
conditions and protecting against degradation agents (humidity, light, pH and gases) 
[111].  Microcapsules are also performing as carriers for drugs delivery, removal of 
fragrances and other compounds to facilitate product handling and improve material 
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ability [34]. For microencapsulation of cells, the selection of a suitable encapsulating 
material is critical. The material is required to have appropriate porosity, which can 
facilitate the transport of nutrients, proteins, DNA, and drug while blocking attack of 
antibodies and immune cells [6]. The capsules must be mechanically stable and easy to 
handle. These requirements may be fulfilled by controlling the pore size and the 
thickness of encapsulating polymer membrane at microscale. Smaller pore size and 
thicker capsules membrane showed higher mechanical stability [112, 113]. The cell 
viability and metabolic status must be optimal if the encapsulated cells are in the order 
of hundreds micron in size [15]. 
 
 
Figure 2.7: Principle of immunoisolation by a microcapsule [15] 
2.6.1 Application of microencapsulation 
Microencapsulation offers the possibility to microencapsulate any substances in 
polymeric materials [6]. It is well known as the promising technique to fabricate novel 
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micro and nanostructured materials applied to a wide variety of applications. There are 
various application of microcapsules that already been introduced in the market.  
One of the most important applications of microencapsulated products is in the 
area of crop protection [114, 115]. Polymer microcapsules, such as gelatin, serve as 
efficient delivery vehicles to deliver pheromone by spraying the capsule dispersion and 
protect the pheromone from oxidation and light during storage and release [116].  
The major applications area of encapsulation technique is pharmaceutical or 
biomedical for controlled drug delivery [117-120]. Several drug delivery systems are 
replacement of therapeutic agents, gene therapy and vaccines use. The capsules are 
engineered to stick tightly to and even penetrate linings in the gastrointestinal track 
before transferring the drug contents over time into circulatory system or the targeted 
spot [119, 121]. Other than that, one of the most important medical applications of 
microencapsulation technology is to serve as a cushion or implant, such as breast 
implant [110]. 
Microencapsulation is used to overcome all the challenges in food industry by 
providing technology to incorporate minerals, vitamins, flavours [122] and essential oils 
in food [123]. Microencapsulation simplify the food manufacturing process by 
converting liquids to solid powder, decreasing production cost, help fragile and sensitive 
materials survive processing and packaging conditions and stabilise the shelf life of the 
active ingredient [124-126]. 
Microencapsulation also plays a crucial role in energy generation field. Hollow 
and multilayered plastic microspheres loaded with gaseous, deuterium, a fusion fuel, are 
used to harness nuclear fusion for producing electrical energy [127]. This fusion 
experiment process has been named as inertial confinement fusion (ICF) and it has been 
in use since 1980s [128]. 
Design and development of nanofiber-based microencapsulation as a novel 
materials by the inclusion of carbonaceous materials such as graphene, in aeronautics-
grade matrixes (thermoplastics and thermoset resins) through the application of 
microcoatings and intermediate microlayers in sandwich panels and reinforcement of 
matrixes have been widely used in aeronautics application. 
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2.6.2 Technologies for microencapsulation of cells 
The encapsulation of various materials and living cells inside capsules for different 
purposes in the pharmaceutical, chemical, food industry, agriculture, tissue engineering, 
biotechnology and medicine is of great importance. Microencapsulation of cells in 
hydrocolloid gel matrices is the technique that the cells are entrapped during gel 
formation, leading to spherical droplets containing cells. Some of the popular 
microencapsulation technologies generally produce the capsules of micron to millimeter 
size for microencapsulation of cells were listed in Table 2.2. 
 
Table 2.2: Comparison of different microencapsulation technologies for encapsulation of 
cells 
 
Micro-
encapsulation 
process 
Cost Complex 
design 
High 
voltage 
Material 
volume   
Uniform Size 
(mm) 
Post-
processing 
/harsh 
treatment 
Reference 
Extrusion Low No No Large No 2 - 10 No [129-131] 
JetCutter 
break-up 
High Yes Yes Large Yes < 1 No [39, 49, 
132-134] 
Spinning disc High Yes No Large Yes 0.2 - 5 No [135] 
Micro nozzle 
array 
High Yes No Large Yes > 0.5 Yes [8, 19] 
Vibration 
nozzle 
Low Yes No Medium No 0.1 - 3 No [37, 136, 
137] 
Coacervation/ 
emulsion 
method 
High Yes No Large Yes 0.02 - 2 Yes [130, 131, 
138, 139] 
Electrostatic 
droplet 
generation 
High Yes Yes Medium Yes > 0.1 No [31-33, 
133] 
Flicking High No No Medium Yes 0.2 - 0.4 No [97] 
Air 
atomisation 
Low No No Medium No 0.08 - 
0.6 
No [35, 140, 
141] 
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2.6.2.1 Extrusion, Jet break-up methods and spinning disc 
Extrusion (Figure 2.8 (a)) is the most common methods widely used to produce 
microcapsules due to its ease, simplicity, low cost, gentle condition and high quantity of 
encapsulated cells. Jet break-up and spinning disc techniques are also originated from 
the extrusion method. In a basic extrusion technique, the alginate containing cells are 
extruded through a syringe needle as droplets into calcium chloride (CaCl2) solution to 
be polymerised. The size and shape of the capsules were influenced by the aperture size 
of the needle, concentration of the CaCl2 solution and the surface tension of the CaCl2 
solution. The basic extrusion technique produced capsules size ranging from 2 - 10 mm 
[129-131]. 
Jet cutter method is suitable to be used with high viscosity polymer solutions 
such as poly(vinyl alcohol) solutions [134]. In this technique, the mixture of cells-
alginate suspension was forced through a nozzle to form liquid jet and then cut by a 
rotating cutting wire (Figure 2.8 (b)). The number of cutting wires, rotations speed of 
cutting tool and the infusion rate manipulates the size of the capsules.  
For the spinning disc technique, the capsules are formed by infusing the cells-
alginate suspension onto the high velocity spinning disc (Figure 2.8 (c)) due to the 
centrifugal force at the edge of the spinning disc, the droplets are formed and dropped 
into the CaCl2 solution to be polymerised. The size of the capsules is controlled by the 
rotating disc speed [142]. This method produces capsules with the size ranged from a 
few hundreds of micrometers up to several millimeters. In contrast to the jet cutting 
method in which, this method is suitable for fluid at low viscosity and it has a very high 
productivity. 
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       (a)      (b)    (c) 
 
Figure 2.8: Schematic diagram of different microencapsulation processes in forming 
microcapsules: (a) Extrusion, (b) Jet cutter and (c) Spinning disc [143] 
2.6.2.2 Micro nozzle array and vibrating nozzle 
Micro nozzle is a developed technique for microencapsulation in year 2000. In this 
technique, the cell-alginate suspension is flew through silicon micro nozzle array and 
then cut off by the high stream of oil to form droplets [8]. The gel droplets drop into the 
oil stream that directs the flow of the droplets to a solution of positive ions (Figure 2.9 
(a)). Due to the high flow pressure conditions, micro nozzle array are suitable to be used 
with high viscosity solution [144]. If this method is to be scaled up for large production, 
the cost of the oil and its disposability could be the limitations of this technique [145]. 
For vibration nozzle technique (Figure 2.9 (b)), the microcapsules are formed by 
oscillating and purging the mixture cells suspension through a nozzle into the hardening 
bath, resulting in size distribution of capsules as 0.1 - 3.0 mm in diameter [137]. 
Collecting 
bath 
Liquid jet 
Cutting 
tool with 
wires 
Spinning 
disc 
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                    (a)                                                                 (b) 
 
Figure 2.9: Schematic diagram of microencapsulation processes in alginate: (a) Micro 
nozzle array [8] and (b) Vibrating nozzle [146] 
2.6.2.3 Microfluidic device 
Microfluidics device has emerged as a powerful platform for the generation of 
microparticles with tailored structure and properties [147-150]. This technique allows 
direct integration of different input fluids into the polydimethylsiloxane (PDMS) 
microfluidic channel as shown in Figure 2.10. The working principle of microfluidic to 
generate microcapsules is based on the emulsification of alginate solution.  
Microcapsule fabrication methods based on microfluidics device may be 
classified into two major approaches, that are flow-focusing and T-junction capsule 
formation. The flow-focusing microfluidic approach, as shown in Figure 2.11, forms 
microcapsules by allowing a core fluid (cell-alginate suspension) to be surrounded by 
sheath stream (oil) flowing. In contrast, T-junctions microfluidic is designed to form 
microcapsules by permitting the core fluid to be swept away by one sheath stream in 
only one direction. A summary of the microfluidic emulsification technologies based on 
PDMS microfluidic chip design for both flow-focusing and T-junction capsules 
formation methods, used for the application of cell encapsulation were listed in Table 
2.3 [6]. 
Alginate CaCl2 
Microcapsules Vegetable 
oil 
Vibration 
of nozzle 
Vibration 
of liquid 
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Figure 2.10: Illustrations of microfluidics system mechanism for microencapsulation 
[151] 
 
 
  (a)     (b) 
 
Figure 2.11: Illustration of microcapsules fabrication methods based on microfluidics 
device. (a) Flow-focusing and (b) T-junction capsules formation [6] 
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